Onco360® Has Been Selected as a National Specialty Pharmacy Partner for Revuforj® (revumenib)
LOUISVILLE, Ky., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a national pharmacy partner by Syndax Pharmaceuticals for Revuforj® (revumenib), as the first and only menin inhibitor …